Cargando…

Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection

Coronavirus disease-2019 (COVID-19) is caused by coronavirus-2 (SARS-CoV-2) and has produced a global pandemic. As of 22 June 2021, 178 million people have been affected worldwide, and 3.87 million people have died from COVID-19. According to the Centers for Disease Control and Prevention (CDC) of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eedara, Basanth Babu, Alabsi, Wafaa, Encinas-Basurto, David, Polt, Robin, Ledford, Julie G., Mansour, Heidi M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308954/ https://www.ncbi.nlm.nih.gov/pubmed/34371768 http://dx.doi.org/10.3390/pharmaceutics13071077

Ejemplares similares

Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols
por: Alabsi, Wafaa, et al.
Publicado: (2022)

Organic Solution Advanced Spray-Dried Microparticulate/Nanoparticulate Dry Powders of Lactomorphin for Respiratory Delivery: Physicochemical Characterization, In Vitro Aerosol Dispersion, and Cellular Studies
por: Alabsi, Wafaa, et al.
Publicado: (2020)

Comprehensive Physicochemical Characterization, In Vitro Membrane Permeation, and In Vitro Human Skin Cell Culture of a Novel TOPK Inhibitor, HI-TOPK-032
por: Eedara, Basanth Babu, et al.
Publicado: (2023)

Dissolution and Absorption of Inhaled Drug Particles in the Lungs
por: Eedara, Basanth Babu, et al.
Publicado: (2022)

Design, Physicochemical Characterization, and In Vitro Permeation of Innovative Resatorvid Topical Formulations for Targeted Skin Drug Delivery
por: Ruiz, Victor H., et al.
Publicado: (2022)

Innovative Rocuronium Bromide Topical Formulation for Targeted Skin Drug Delivery: Design, Comprehensive Characterization, In Vitro 2D/3D Human Cell Culture and Permeation
por: Ruiz, Victor H., et al.
Publicado: (2023)

Synthesis, Physicochemical Characterization, In Vitro 2D/3D Human Cell Culture, and In Vitro Aerosol Dispersion Performance of Advanced Spray Dried and Co-Spray Dried Angiotensin (1—7) Peptide and PNA5 with Trehalose as Microparticles/Nanoparticles for Targeted Respiratory Delivery as Dry Powder Inhalers
por: Alabsi, Wafaa, et al.
Publicado: (2021)

Glycosylated Ang-(1-7) MasR Agonist Peptide Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles and Microparticles in Cognitive Impairment: Design, Particle Preparation, Physicochemical Characterization, and In Vitro Release
por: Encinas-Basurto, David, et al.
Publicado: (2022)

Inhalable Combination Powder Formulations for Treating Latent and Multidrug-Resistant Tuberculosis: Formulation and In Vitro Characterization
por: Eedara, Basanth Babu, et al.
Publicado: (2023)

Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers
por: Acosta, Maria F., et al.
Publicado: (2020)

Angiotensin-(1–7) Peptide Hormone Reduces Inflammation and Pathogen Burden during Mycoplasma pneumoniae Infection in Mice
por: Collins, Katie L., et al.
Publicado: (2021)

A STELLA simulation model for in vitro dissolution testing of respirable size particles
por: Eedara, Basanth Babu, et al.
Publicado: (2019)

Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation
por: Eedara, Basanth Babu, et al.
Publicado: (2021)

PNA6, a Lactosyl Analogue of Angiotensin-(1-7), Reverses Pain Induced in Murine Models of Inflammation, Chemotherapy-Induced Peripheral Neuropathy, and Metastatic Bone Disease
por: Sulaiman, Maha I., et al.
Publicado: (2023)

Inhaled medical aerosols by nebulizer delivery in pulmonary hypertension
por: Mansour, Heidi M.
Publicado: (2018)

Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols
por: Muralidharan, Priya, et al.
Publicado: (2020)

Inhalable PEGylated Phospholipid Nanocarriers and PEGylated Therapeutics for Respiratory Delivery as Aerosolized Colloidal Dispersions and Dry Powder Inhalers
por: Muralidharan, Priya, et al.
Publicado: (2014)

Design, Development, Physicochemical Characterization, and In Vitro Drug Release of Formoterol PEGylated PLGA Polymeric Nanoparticles
por: Vallorz, Ernest L., et al.
Publicado: (2022)

Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia
por: Hoyer-Kimura, Christina, et al.
Publicado: (2021)

Asthma diagnosis and treatment – 1018. Effect of inhaled corticosteroids with long-acting beta2 agonists vs. inhaled corticosteroids alone on asthma control in children: results from national ashtma survey
por: Lockey, Richard F, et al.
Publicado: (2013)

Nanomedicine formulations for respiratory infections by inhalation delivery: Covid-19 and beyond
por: Zachar, Oron
Publicado: (2022)

Inhaled Liposomal Antimicrobial Delivery in Lung Infections
por: Bassetti, Matteo, et al.
Publicado: (2020)

Inhaled Antibiotics for the Prevention of Respiratory Tract Infections in Children With a Tracheostomy
por: Jutras, Camille, et al.
Publicado: (2021)

Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried cyclosporine A multifunctional particles for dry powder inhalation aerosol delivery
por: Wu, Xiao, et al.
Publicado: (2013)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
por: Gauani, Helena, et al.
Publicado: (2023)

Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery
por: Duan, Jinghua, et al.
Publicado: (2013)

CNS active O-linked glycopeptides
por: Jones, Evan M., et al.
Publicado: (2015)

Advanced Microparticulate/Nanoparticulate Respirable Dry Powders of a Selective RhoA/Rho Kinase (Rock) Inhibitor for Targeted Pulmonary Inhalation Aerosol Delivery
por: Muralidharan, Priya, et al.
Publicado: (2021)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Gold Nanorods with Mesoporous Silica Shell: A Promising Platform for Cisplatin Delivery
por: Quiñones, Jaime, et al.
Publicado: (2023)

Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols
por: Meenach, Samantha A, et al.
Publicado: (2013)

Targeting Drug Delivery to the Lungs by Inhalation
por: O'Callaghan, C.
Publicado: (1994)

Oligonucleotide Delivery to the Lung: Waiting to Inhale
por: Kjems, Jørgen, et al.
Publicado: (2012)

Inhaled nano- and microparticles for drug delivery
por: El-Sherbiny, Ibrahim M., et al.
Publicado: (2015)

Emerging trends in inhaled drug delivery
por: Hickey, Anthony J.
Publicado: (2020)

Development and Validation of a Rapid High-Performance Liquid Chromatography–Tandem Mass Spectrometric Method for Determination of Folic Acid in Human Plasma
por: Zayed, Aref, et al.
Publicado: (2018)

Particle Design and Inhalation Delivery of Iodine for Upper Respiratory Tract Infection Therapy
por: Zhang, Kaikai, et al.
Publicado: (2022)

Inhalable antibodies for the treatment of COVID-19
por: Yang, Zhenlin, et al.
Publicado: (2022)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

(S)-Methyl 2-{(S)-2-[bis(4-methoxyphenyl)methylideneamino]-3-hydroxypropanamido}-3-methylbutanoate
por: Keyari, Charles M., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_v79vpauutig4o1kijfbvo27ncs